RPS6KA1 and acute myeloid leukemia: Inhibition of PIM by its specific inhibitor AZD1208 [23] failed to affect expression levels of RSK1 and RSK2 also in primary AML cells, although it slightly inhibited RSK NTKD and CTKD.